Anheuser-Busch InBev SA/NV (BUD) EBT (2015 - 2026)

Anheuser-Busch InBev (BUD) has reported EBT for 12 consecutive years, with $6.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 11.41% year-over-year to $6.0 billion; the trailing twelve-month figure through Jun 2026 stood at $21.3 billion (up 6.73% YoY), and the FY2025 full-year result was $11.3 billion, up 7.19% from the prior year.
• EBT improved to $6.0 billion in Q2 2026 per BUD's latest filing, from $5.2 billion in the prior quarter.
• Across five years, EBT topped out at $7.9 billion in Q2 2022 and bottomed at $2.1 billion in Q1 2022.
• Historically, EBT has averaged $4.5 billion across 5 years, with a median of $4.2 billion in 2022.
• The sharpest annual moves came in 2022 and 2023: EBT soared 191.79% in 2022, then slumped 55.32% in 2023.
• Over 5 years, EBT stood at $3.6 billion in 2022, then fell by 8.32% to $3.3 billion in 2023, then soared by 51.88% to $5.1 billion in 2024, then declined by 6.77% to $4.7 billion in 2025, then increased by 26.86% to $6.0 billion in 2026.
• According to Business Quant data, EBT over the past three periods registered $6.0 billion, $5.2 billion, and $4.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.